MitoRx Therapeutics is a pre-clinical stage rare disease biotech company aiming to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction, with a focus on neuromuscular disease, metabolic disease and neurodegenerative disease.


MitoRx Therapeutics

MitoRx Therapeutics' headquarters in Oxford, United Kingdom

Jon Rees

Hanna Dickenson

Xavier Jacq

Matt Whiteman

Norman Law

Glyn Edwards

Chas Bountra

Dame Kay Davies

Laurent Servais

Bernd C. Schwahn

Alexander Fink

The Scientific Advisory Team at MitoRx Therapeutics provides expert guidance on research and development strategies to advance therapies targeting mitochondrial dysfunction. Comprised of distinguished scientists and advisors, the team collaborates to ensure the scientific integrity and innovation of the company's pre-clinical programs, with a focus on neuromuscular, metabolic, and neurodegenerative diseases.

Scientific Advisory Team

The Leadership Team at MitoRx Therapeutics drives the company's strategic vision and operational execution, focusing on innovation in therapies for rare neurodegenerative diseases linked to mitochondrial dysfunction. Comprising key executives with expertise in development, intellectual property, and scientific research, the team collaboratively fosters a culture of excellence to advance pre-clinical initiatives, secure funding, and establish MitoRx as a leader in the biotech industry.

MitoRx Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Offices

MitoRx Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Offices

Related companies